For atrial fibrillation, oral anti-coagulation remains the treatment of choice despite the potential of an anti-platelet regimen based on aspirin and clopidogrel, according to the ACTIVE-W trial. Stuart Connolly from McMaster University presented the findings.
[audio:https://www.audiomedica.com/podcasting/aha2005/Stuart_Connolly.mp3]
Young adults less likely to be diagnosed with hypertension than over 60s 31 Dec, 2012 
Eicosapentaenoic Acid: Prevention of Coronary Artery Disease 17 Nov, 2005 Heart Attacks Drop After Smoking Ban in Ireland 5 Sep, 2007 Angiotensin AT2 Receptor Agonist: Restorative Role For Patients With Hypertension? 29 Jun, 2009 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
